Neonatal mass screening for 21-hydroxylase deficiency.

about

Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.

P2860

Q36251774-5BA1BA71-B897-4E59-A90C-945383F8610B

P2860

Neonatal mass screening for 21-hydroxylase deficiency.

Item

http://www.wikidata.org/entity/Q36535856

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Neonatal mass screening for 21-hydroxylase deficiency.

@ast

Neonatal mass screening for 21-hydroxylase deficiency.

@en

type

Item

label

Neonatal mass screening for 21-hydroxylase deficiency.

@ast

Neonatal mass screening for 21-hydroxylase deficiency.

@en

prefLabel

Neonatal mass screening for 21-hydroxylase deficiency.

@ast

Neonatal mass screening for 21-hydroxylase deficiency.

@en

P1476

Neonatal mass screening for 21-hydroxylase deficiency.

@en

P2093

Masaru Fukushi

http://www.w3.org/2001/XMLSchema#string

Toshihiro Tajima

http://www.w3.org/2001/XMLSchema#string

P2860

Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Use of steroid profiling by UPLC-MS/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience.

Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision)

Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE).

Results from 28 years of newborn screening for congenital adrenal hyperplasia in sapporo.

Neonatal screening for congenital adrenal hyperplasia in Japan.

Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.

P304

1-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1297/CPE.25.1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

292343482

http://www.w3.org/2001/XMLSchema#string

P698

26865749

http://www.w3.org/2001/XMLSchema#string

P932

4738187

http://www.w3.org/2001/XMLSchema#string

Neonatal mass screening for 21-hydroxylase deficiency.

about

P2860

P2860

Neonatal mass screening for 21-hydroxylase deficiency.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932